Siyi Zou

Shanghai Jiao Tong University

Papers

1

Total Citations

8

H-Index

1

About

Dr. Siyi Zou is a surgical oncologist whose research focuses on prognostic biomarkers in pancreatic cancer, particularly the role of coagulation and fibrinolytic markers in predicting patient outcomes. Her most cited work, "Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection" (2021, 8 citations), addresses a critical gap in the literature by demonstrating that elevated preoperative D-dimer levels serve as an independent predictor of poor survival in patients with pancreatic ductal adenocarcinoma after radical surgery. This finding challenges the controversy surrounding D-dimer's clinical significance in this context and provides surgeons with a readily available, low-cost tool for preoperative risk stratification. By systematically analyzing coagulation parameters in a large surgical cohort, Dr. Zou has contributed valuable evidence supporting the integration of D-dimer into prognostic models for pancreatic cancer. Her work underscores the importance of tumor-associated coagulopathy in cancer biology and offers practical implications for personalized surgical decision-making. Dr. Zou's research continues to advance the understanding of how routine laboratory markers can enhance prognostic accuracy in one of the most lethal malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Shanghai Jiao Tong University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago